rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 50

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-04954 · 2020

GHRH Receptor Drives Eye Inflammation Through JAK2/STAT3 — Blocking It Reduces Uveitis

GHRH-R specifically activates JAK2/STAT3 signaling in ocular inflammation; both the GHRH-R antagonist MIA-602 and JAK inhibitor ruxolitinib reduced acute uveitis.

Liang, Wei Cheng; Ren, Jia Lin; Yu, Qiu Xiao; Li, Jian; Ng, Tsz Kin; Chu, Wai Kit; Qin, Yong Jie; Chu, Kai On; Schally, Andrew V; Pang, Chi Pui; Chan, Sun On · Animal Study

RPEP-04961 · 2020

Mosquito Defensin C Fights Dengue Virus Through the Ras/ERK Immune Signaling Pathway

Ras/ERK signaling activates defensin C in Aedes mosquitoes to restrict DENV infection; ERK knockdown (but not JNK or p38) significantly enhanced viral replication.

Liu, Wen-Quan; Chen, Si-Qi; Bai, Hao-Qiang; Wei, Qi-Mei; Zhang, Sheng-Nan; Chen, Chen; Zhu, Yi-Han; Yi, Tang-Wei; Guo, Xiao-Pu; Chen, Si-Yuan; Yin, Meng-Jie; Sun, Chen-Feng; Liang, Shao-Hui · In Vitro

RPEP-04963 · 2020

Thymosin Alpha 1 Cut Severe COVID-19 Death Rate from 30% to 11% by Restoring T Cell Function

Tα1 reduced severe COVID-19 mortality from 30% to 11.1% (P=.044), restored CD4+ and CD8+ T cell counts, and reversed T cell exhaustion markers (PD-1, Tim-3).

Liu, Yueping; Pan, Yue; Hu, Zhenhong; Wu, Ming; Wang, Chenhui; Feng, Zeqing; Mao, Congzheng; Tan, Yingjun; Liu, Ying; Chen, Li; Li, Min; Wang, Gang; Yuan, Zilin; Diao, Bo; Wu, Yuzhang; Chen, Yongwen · Retrospective

RPEP-04967 · 2020

Mice Carrying the Human LL-37 Gene Show Vitamin D Boosts Wound Healing and Staph Killing

CAMP transgenic mice showed increased Salmonella resistance, restored wound healing in Camp-KO skin, and topical vitamin D induced LL-37 expression with enhanced S. aureus killing in wounds.

Lowry, Malcolm B; Guo, Chunxiao; Zhang, Yang; Fantacone, Mary L; Logan, Isabelle E; Campbell, Yan; Zhang, Weijian; Le, Mai; Indra, Arup K; Ganguli-Indra, Gitali; Xie, Jingwei; Gallo, Richard L; Koeffler, H Phillip; Gombart, Adrian F · Animal

RPEP-04974 · 2020

Self-Assembling Peptide-Adjuvant Nanoparticles Induce Anti-Cancer T Cells Against 50% of Tested Neoantigens

SNP-7/8a self-assembled nanoparticles induced CD8 T cells against ~50% of high-affinity predicted neoantigens (179 tested) and enhanced tumor clearance in three mouse models, with immunogenicity confirmed in primates.

Lynn, Geoffrey M; Sedlik, Christine; Baharom, Faezzah; Zhu, Yaling; Ramirez-Valdez, Ramiro A; Coble, Vincent L; Tobin, Kennedy; Nichols, Sarah R; Itzkowitz, Yaakov; Zaidi, Neeha; Gammon, Joshua M; Blobel, Nicolas J; Denizeau, Jordan; de la Rochere, Philippe; Francica, Brian J; Decker, Brennan; Maciejewski, Mateusz; Cheung, Justin; Yamane, Hidehiro; Smelkinson, Margery G; Francica, Joseph R; Laga, Richard; Bernstock, Joshua D; Seymour, Leonard W; Drake, Charles G; Jewell, Christopher M; Lantz, Olivier; Piaggio, Eliane; Ishizuka, Andrew S; Seder, Robert A · Animal

RPEP-04976 · 2020

Insulin Directly Modulates Pain-Sensing Neurons Through Neuropeptide Interactions

Insulin receptors are expressed on a specific subset of sensory neurons in both the central and peripheral nervous system. Quantitative studies revealed that visceral (organ-supplying) sensory neurons express more insulin receptors than somatic (skin/muscle) sensory neurons. InsR co-localizes with TRPV1 (a pain channel), CGRP, and substance P in these neurons. This co-expression means insulin signaling can directly modulate pain transmission and neurogenic inflammation. The functional significance includes modulation of ion channels involved in pain, regulation of neuropeptide release (CGRP and substance P), and neurotrophic effects on nerve growth, development, and regeneration. Recent studies reveal important roles for insulin in axonal growth and repair.

Lázár, Bence András; Jancsó, Gábor; Sántha, Péter · Review

RPEP-04984 · 2020

GLP-1 Drugs Reduce Heart Attacks, Strokes, and Death by 12% in 56,000 Diabetic Patients — Even Without Prior Heart Disease

GLP-1 receptor agonists reduced 3-point MACE by 12% (HR 0.88), stroke by 16%, CV death by 12%, all-cause mortality by 11%, and HF hospitalization by 8% across 56,004 patients — with no significant difference between those with or without established CVD.

Marsico, Fabio; Paolillo, Stefania; Gargiulo, Paola; Bruzzese, Dario; Dell'Aversana, Simona; Esposito, Immacolata; Renga, Francesco; Esposito, Luca; Marciano, Caterina; Dellegrottaglie, Santo; Iesu, Ivana; Perrone Filardi, Pasquale · Meta Analysis